The orthopedic biomaterials market is expected to reach USD 24.86 billion by 2030 from USD 16.95 billion in 2025, at a CAGR of 8.0% between 2025 and 2030. The growth of the orthopedic biomaterials market can be attributed to several factors, including the growing aging population, the rising incidence of osteoarthritis, osteoporosis, and joint degeneration, as well as the increasing number of orthopedic procedures, such as hip, knee, spine, and trauma surgeries.
Key players in the orthopedic biomaterials industry include Celanese Corporation (US), Carpenter Technology Corporation (US), Evonik Industries AG (Germany), DSM (Netherlands), Corbion NV (Netherlands), CoorsTek Inc (US), Berkeley Advanced Materials (US), and CAM Bioceramics B.V. (Netherlands). In March 2025, Celanese Corporation expanded its medical-grade UHMWPE portfolio for orthopedic implants, supporting improved wear resistance and longer implant life in hip and knee replacement applications, reinforcing its position as a key materials supplier to global orthopedic OEMs.
To know about the assumptions considered for the study download the pdf brochure
Celanese Corporation (US)
Celanese supplies advanced medical-grade polymers, such as GUR UHMW-PE and implantable MT-series thermoplastics, which are used in orthopedic joint, spine, and trauma implants. These polymers offer high wear resistance, biocompatibility, and radiolucency for durable, imaging-friendly components. These materials support both metal-on-polyethylene and metal-free designs, helping orthopedic OEMs reduce debris generation, enable minimally invasive instrumentation, and secure long-term, globally qualified raw-material supply chains for critical load-bearing devices.
Carpenter Technology Corporation (US)
Carpenter Technology offers a comprehensive portfolio of specialty stainless steels, titanium alloys, and proprietary BioDur grades, including BioDur 108 and BioDur CCM, which are engineered for articulating hip and knee components, fixation plates, and spinal hardware that require high fatigue strength and corrosion resistance. By combining powder-metal and wrought processing routes, these alloys deliver improved wear performance, reduced nickel and cobalt content for sensitive patients, and tight bar/forging tolerances, helping orthopedic manufacturers meet demanding reliability and regulatory requirements in joint replacement and trauma systems.
Evonik Industries AG (Germany)
Evonik’s Healthcare business offers RESOMER bioresorbable polymers (PLA, PLGA, PCL) and VESTAKEEP PEEK biomaterials that target orthopedic applications, ranging from interference screws, suture anchors, and fracture plates to spinal cages and sports medicine implants, which require tailored degradation and high mechanical strength. These biomaterials combine proven biocompatibility, sterilization stability, and tunable modulus with benefits such as radiolucency and bone-like stiffness, enabling OEMs to design metal-free or partially resorbable orthopedic systems that support bone regeneration, simplify revision imaging, and reduce the need for secondary hardware-removal surgeries.
Market Ranking
The orthopedic biomaterials market for raw materials is led by Celanese, followed by Carpenter Technology, Evonik Industries, DSM, and Corbion NV. These companies set the standards for polymer implants and alloys. Celanese offers a range of ultra-high-molecular-weight polyethylene (UHMWPE) for use in joint bearings. Carpenter Technology specializes in high-performance stainless steel and cobalt-chrome alloys used in load-bearing hardware. Evonik Industries provides both bioresorbable RESOMER polymers and VESTAKEEP PEEK, which are suitable for metal-free or degradable implants. DSM and Corbion contribute to the bio-based materials sector, adding strength and sustainability. Other notable materials include biocomposites and PLA/PLGA resorbable polymers, which facilitate tissue-supportive and next-generation resorbable orthopedic systems.
Related Reports:
Orthopedic Biomaterials Market By Type (Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, Natural Biomaterials), Application (Joint Replacement, Spine Surgery, Bioresorbable Tissue Fixation, Orthobiologics, Fracture Fixation) - Forecast to 2030
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE